2002
DOI: 10.1034/j.1600-0714.2002.00123.x
|View full text |Cite
|
Sign up to set email alerts
|

The potential use of saliva to detect recurrence of disease in women with breast carcinoma

Abstract: This preliminary study appears to indicate that c-erbB-2 protein expression in saliva may be a very useful diagnostic tool for measuring patient response to chemotherapy and/or surgical treatment of their disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
57
0
3

Year Published

2005
2005
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 78 publications
(65 citation statements)
references
References 34 publications
1
57
0
3
Order By: Relevance
“…Breast cancer mortality level decreased and this has been attributed to: the early diagnosis (characterization of prognosis and diagnosis factors) and the treatment with adjuvant chemotherapy, hormonal therapy and target therapy (Xiaoqiang, 2013). Despite the advanced testing methods, like mammography, these procedures may produce a large percentage of false positives and false negatives, especially in women with dense breast tissues (Bigler et al, 2002;Dilhuydy, 2009;Tarhan et al, 2013). Consequently, studies have big interest in tumor markers, substances detected in the circulation of patients with malignant tumors, which could be used in all stages of cancer care (screening, diagnosis, treatment and metastasis prediction) (Porika et Maric et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Breast cancer mortality level decreased and this has been attributed to: the early diagnosis (characterization of prognosis and diagnosis factors) and the treatment with adjuvant chemotherapy, hormonal therapy and target therapy (Xiaoqiang, 2013). Despite the advanced testing methods, like mammography, these procedures may produce a large percentage of false positives and false negatives, especially in women with dense breast tissues (Bigler et al, 2002;Dilhuydy, 2009;Tarhan et al, 2013). Consequently, studies have big interest in tumor markers, substances detected in the circulation of patients with malignant tumors, which could be used in all stages of cancer care (screening, diagnosis, treatment and metastasis prediction) (Porika et Maric et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Such an examination might be of great benefit because of the direct contact between the oral cancer lesion and saliva, particularly because salivary analysis is a useful diagnostic tool for other distant malignancies, such as breast carcinoma (24). Moreover, these scarce salivary reports focused only on one commonly analyzed tumor marker, the CEA (25,26), which did not prove to be sensitive or specific enough.…”
mentioning
confidence: 99%
“…A partir da análise em saliva, o fragmento solúvel do oncogene c-erbB-2, um marcador prognóstico do câncer de mama, bem como o antígeno 15-3 para câncer (CA15-3), foram significativamente maiores na saliva e no soro de mulheres com diagnóstico de câncer que o observado em um grupo controle de mulheres saudáveis e indivíduos com tumores benignos. Adicionalmente, o uso do teste salivar pode ser importante no monitoramento dos níveis de c-erbB-2 em pacientes em tratamento quimioterápico e/ou cirúrgico, de forma que serve como avaliação da efetividade terapêutica em questão, bem como, pode ser útil na proservação (BIGLER et al,2002).…”
Section: Doenças Neoplásicas Malignasunclassified